Clinical Trial

Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure

Study acronym: KADHEF-2
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will evaluate the feasibility and safety of achieving therapeutic concentrations of beta-hydroxybutyrate using continuous infusion of D-beta-hydroxybutyrate monoester administered via a nasogastric tube in patients with acutely decompensated heart failure with reduced left ventricular ejection fraction.
Trial Details
NCT Number NCT07527156
Lead Sponsor Institute for Clinical and Experimental Medicine
Conditions Acute Heart Failure (AHF), Cardiogenic Shock, Heart Failure, Ketones, Ketone Body Metabolism
Enrollment 12 participants
Start Date 2026-04-04
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-14